OTLC stock

Oncotelic Therapeutics Inc (OTLC) financials · $17.8M cap

Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT

Oncotelic Therapeutics Inc (OTLC) $17.8M cap.

Cached annual income statement
LineFY2025FY2024
Operating Income-$3.19M-$3.58M
Net Income$249.3M-$4.52M
EPS (Diluted)$0.59-$0.01
Cached annual balance sheet
LineFY2025FY2024
Total Assets$393.1M$26.7M
Current Assets$1.20M$134.2K
Cash & Equivalents$88.9K$86.1K
Total Liabilities$131.4M$19.2M
Current Liabilities$18.1M$19.2M
Short-term DebtN/A$2.42M
Total DebtN/A$2.42M
Shareholders' Equity$262.8M$8.25M
Retained Earnings$211.2M-$38.0M

† Total Debt: Derived from short-term debt only (no total or long-term debt stored).

Cached annual cash flow
LineFY2025FY2024
Operating Cash Flow-$1.38M-$740.3K
Financing Cash Flow$1.39M$656.0K
Net Change in Cash$2.73KN/A
These statements as JSON? API free 100/day

FAQ

What is OTLC P/E and revenue?

Oncotelic Therapeutics Inc (OTLC) $17.8M cap.

What is OTLC revenue?

OTLC income-statement cache has no revenue figure yet.

Is OTLC profitable?

Oncotelic Therapeutics Inc last cached net income is $249.3M (FY2025).

What are OTLC total assets?

Oncotelic Therapeutics Inc last cached total assets are $393.1M (FY2025).

What is OTLC free cash flow?

No cached cash-flow row for OTLC yet.

Not investment advice. Cached statements, not a live tape.